Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V. Moorman, Gordon W. Dewald, Adele K. Fielding et al.|Blood|2006Cited by 746
Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12Christine J. Harrison, Brenda Gibson, Robert K. Hills et al.|Journal of Clinical Oncology|2010Cited by 305
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaChristine J. Harrison, Anthony V. Moorman, Zoë J. Broadfield et al.|British Journal of Haematology|2004Cited by 234
Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)Anthony V. Moorman, Christine J. Harrison, Susan Richards et al.|Blood|2006Cited by 221
Clinical and Prognostic Impact of Copy Number Alterations and Associated Risk Profiles in a Cohort of Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Cases Treated Under ICiCLe ProtocolSanjeev Gupta, Prateek Bhatia, Srinivasan Peyam et al.|HemaSphere|2022Cited by 16